In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 1, Pages e001481
Publisher
BMJ
Online
2021-01-22
DOI
10.1136/jitc-2020-001481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
- (2020) Elisa A. Rozeman et al. MELANOMA RESEARCH
- Intrinsic cancer vaccination
- (2019) Yoosoo Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- An optimized protocol to determine the engulfment of cancer cells by phagocytes using flow cytometry and fluorescence microscopy
- (2019) Gi-Hoon Nam et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types
- (2019) Monique K. van der Kooij et al. Cancers
- Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity
- (2019) Yeonsun Hong et al. Journal of Extracellular Vesicles
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade
- (2019) Youngmin Jeong et al. CANCER LETTERS
- Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
- (2018) Eun Jung Lee et al. ADVANCED MATERIALS
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA
- (2018) Elif B. Turkoglu et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
- (2018) Gi-Hoon Nam et al. Nature Communications
- Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction
- (2018) Ziad Al Bkhetan et al. Scientific Reports
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma
- (2017) I D Fabian et al. EYE
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
- (2017) Smita S Chandran et al. LANCET ONCOLOGY
- A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy
- (2017) Malinda Itchins et al. MELANOMA RESEARCH
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- BRACHYTHERAPY ALONE OR WITH NEOADJUVANT PHOTODYNAMIC THERAPY FOR AMELANOTIC CHOROIDAL MELANOMA
- (2016) Maria A. Blasi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture
- (2015) C L Shields et al. EYE
- Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma
- (2015) Kavita K. Mishra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
- (2014) Kalijn F. Bol et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
- (2014) M T Huggett et al. BRITISH JOURNAL OF CANCER
- Treatment of posterior uveal melanoma with multi-dose photodynamic therapy
- (2014) Paul Rundle BRITISH JOURNAL OF OPHTHALMOLOGY
- Plaque Radiotherapy for Juxtapapillary Choroidal Melanoma
- (2014) Mandeep S. Sagoo et al. JAMA Ophthalmology
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?
- (2012) Elisa Panzarini et al. Biomed Research International
- Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma
- (2011) J de Lange et al. ONCOGENE
- Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity
- (2010) Mutsuki Amano et al. Cytoskeleton
- Heavy-Atomic Construction of Photosensitizer Nanoparticles for Enhanced Photodynamic Therapy of Cancer
- (2010) Chang-Keun Lim et al. Small
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started